Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies

被引:43
|
作者
Scosyrev, Emil [1 ]
Tobis, Scott [1 ]
Donsky, Heather [1 ]
Wu, Guan [1 ]
Joseph, Jean [1 ]
Rashid, Hani [1 ]
Messing, Edward [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA
关键词
biochemical recurrence; biochemical failure; prostate cancer; statins; RADICAL PROSTATECTOMY; CLINICAL PRESENTATION; PUBLICATION BIAS; ANTIGEN LEVELS; POPULATION; OUTCOMES; IMPACT; MEN;
D O I
10.1111/j.1464-410X.2012.11527.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
What's known on the subject? and What does the study add? Over the last few years, several observational studies examined the association of statin use with the risk of biochemical recurrence of prostate cancer after definitive local therapy. The objective of our present study was to summarise available evidence on this subject using the method of meta-analysis. Combined evidence from eight cohort studies did not definitively support the hypothesis that statins influence the risk of biochemical recurrence. However, there was considerable disagreement between individual studies in reported findings and conclusions. OBJECTIVE center dot To perform a systematic review and meta-analysis of clinical studies with statin use as the exposure variable and biochemical recurrence after definitive local therapy for prostate cancer as the outcome. METHODS center dot Relevant publications were identified through PubMed/Medline/Embase databases. center dot Pooled estimates of the hazard ratios (HRs) were computed using the inverse-variance weighting approach. center dot Heterogeneity was assessed using the Cochran's Q test. RESULTS center dot We identified a total of eight eligible studies, all based on the retrospective cohort design. Five of these were based on radical prostatectomy (RP) series and three on radiotherapy (RT) series. center dot There was evidence of heterogeneity in the entire set of eight studies (P= 0.002) as well as in the RP series (P= 0.05) and in the RT series (P= 0.01), when these were considered separately. center dot Based on the random effects inverse-variance weighting approach, pooled estimates of the HRs for the risk of biochemical recurrence in statin users v non-users were 0.91 (95% confidence interval [CI] 0.721.13) for the entire set of eight studies, 1.02 (95% CI 0.801.29) for the RP series and 0.71 (95% CI 0.441.16) for the RT series. CONCLUSION center dot The pooled estimates of the HRs were not significantly different from the null value in this meta-analysis; however, evidence of heterogeneity between the studies was present.
引用
收藏
页码:E71 / E77
页数:7
相关论文
共 50 条
  • [11] Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy
    Prabhu, Nicole
    Kapur, Navina
    Catalona, William
    Leikin, Robin
    Helenowski, Irene
    Jovanovich, Borko
    Gurley, Michael
    Okwuosa, Tochi M.
    Kuzel, Timothy M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (02) : 130.e9 - 130.e15
  • [12] Management of Patients with Biochemical Recurrence After Local Therapy for Prostate Cancer
    Paller, Channing J.
    Antonarakis, Emmanuel S.
    Eisenberger, Mario A.
    Carducci, Michael A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (06) : 1205 - +
  • [13] Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer
    McKay, Rana R.
    Gray, Kathryn P.
    Hayes, Julia H.
    Bubley, Glenn J.
    Rosenberg, Jonathan E.
    Hussain, Arif
    Kantoff, Philip W.
    Taplin, Mary-Ellen
    CANCER, 2015, 121 (15) : 2603 - 2611
  • [14] Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis
    Matsukawa, Akihiro
    Yanagisawa, Takafumi
    Fazekas, Tamas
    Miszczyk, Marcin
    Tsuboi, Ichiro
    Kardoust Parizi, Mehdi
    Laukhtina, Ekaterina
    Klemm, Jakob
    Mancon, Stefano
    Mori, Keiichiro
    Kimura, Shoji
    Miki, Jun
    Gomez Rivas, Juan
    Soeterik, Timo F. W.
    Zilli, Thomas
    Tilki, Derya
    Joniau, Steven
    Kimura, Takahiro
    Shariat, Shahrokh F.
    Rajwa, Pawel
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024,
  • [15] Clinical significance and treatment of biochemical recurrence after definitive therapy for localized prostate cancer
    Roberts, Wilmer B.
    Han, Misop
    SURGICAL ONCOLOGY-OXFORD, 2009, 18 (03): : 268 - 274
  • [16] Post-diagnostic metformin and statin use and risk of biochemical recurrence in Veterans diagnosed with prostate cancer
    Khan, Saira
    Chang, Su-Hsin
    Seyerle, Amanda A. A.
    Wang, Mei
    Hicks, Veronica
    Drake, Bettina F. F.
    PROSTATE, 2023, 83 (12) : 1150 - 1157
  • [17] Statin use and mortality of patients with prostate cancer: a meta-analysis
    Meng, Yang
    Liao, Yan-Biao
    Xu, Peng
    Wei, Wu-Ran
    Wang, Jia
    ONCOTARGETS AND THERAPY, 2016, 9 : 1689 - 1696
  • [18] Statin Use after Radical Prostatectomy Reduces Biochemical Recurrence in Men With Prostate Cancer
    Song, Cheryn
    Park, Sejun
    Park, Jinsung
    Shim, Myungsun
    Kim, Aram
    Jeong, In Gab
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    PROSTATE, 2015, 75 (02) : 211 - 217
  • [19] Effect of phosphodiesterase type 5 inhibitors on prostate cancer risk and biochemical recurrence after prostate cancer treatment: A systematic review and meta-analysis
    Wu, Yougen
    Qu, Xiaofeng
    Wang, Yang
    Xia, Ju
    Gu, Yuting
    Qian, Qingqing
    Hong, Yang
    ANDROLOGIA, 2019, 51 (02)
  • [20] Effect of Salvage Radiotherapy and Endocrine Therapy on Patients with Biochemical Recurrence After Prostate Cancer Operation- a Meta-Analysis
    Yuan, Yong
    Zhang, Qiang
    Xie, Chaofan
    Wu, Tao
    AMERICAN JOURNAL OF MENS HEALTH, 2021, 15 (03)